RSS

Japan

An exclusive distribution agreement has been signed by Johnson Matthey and DKSH, involving the distribution of high-technology catalysts in Japan. more

News

Global active pharmaceutical ingredient (API) developer and manufacturer, Sterling Pharma Solutions, has experienced growth within the Japanese market and as such is now working with numerous clients in the region. more

News

A recent report from CPhI Japan has forecast that this year, 2018, will be a transformative year for Japanese pharma as the market is expected to see growth in generics, biosimilars and internationalisation. more

Analysis

The biggest UK life sciences delegation headed to the Asia-Pacific region earlier this week to demonstrate the sector’s strengths and to foster collaborations at the region’s largest biosciences conference, BioJapan — Yokohama, Japan. more

News

Developer of next-generation transdermal drug delivery patches, Medherant, has signed an agreement with a Japanese transdermal patch company to evaluate the potential of the TEPI Patch technology. more

Technology

Global contract research organisation (CRO), Chiltern, has acquired Integrated Development Associates (IDA), which is a CRO that specialises in integrating Japan and Asia into global drug development. more

News

Freeman Technology, a company specialising in powder characterisation, has expanded its global presence further with the establishment of an office in Japan. more

News

According to research released at CPhI Japan, domestic companies are forecasting a 17% growth in the Japanese pharmaceutical economy. more

News

Recipharm, the contract development and manufacturing organization (CDMO), has entered into a long-term agreement with Sato Pharmaceuticals for the commercial manufacture and delivery of Emla Patch to Japanese market. more

News

This year CPhI Japan will return to the Tokyo Big Sight Centre for its 16th edition to provide the latest trends, insights and advancements in the pharmaceutical industry. more

News

Japanese researchers have used lasers to induce selective crystallisation of metastable indomethacin, paving the way for the synthesis of APIs that can change their form. more

News

France's Sanofi and US partner Regeneron Pharmaceuticals have reported that the phase 3 trial of drug Praluent reduced cholesterol in 69% of Japanese patients in a phase 3 trial. more

News

The Ministry of Health, Labor and Welfare in Japan has granted marketing authorisation for Sanofi's insulin glargine [rDNA origin] injection, 300 u/ml, a next-generation basal insulin for the treatment of type 1 and type 2 diabetes mellitus. more

News

Novasep, a supplier of services and technologies for the life sciences and chemical industries, is expanding its presence in Asia by signing two partnership agreements for the Japanese market. more

News

BIOTRONIK has launched the portable data-transmitter device CardioMessenger Smart 3G in Japan. more

Technology

As part of the agreement, BMS and Ono will jointly develop and commercialise Opdivo (nivolumab) and Yervoy (ipilimumab) across a broad range of tumour types. more

Process and packaging technology solutions provider Bosch Packaging Technology has moved to a new location at Musashi, some 70 km north of Tokyo. Since the move in late March, over 100 associates have been developing and manufacturing inspection... more

Technology

Recipharm was informed on 20 September 2013 by the R&D-based pharmaceutical company Kyowa Hakko Kirin Co. Ltd. that the Abstral sublingual (under the tongue) tablet has been approved for manufacturing and marketing by Japan's Ministry of Health... more

Technology

Recipharm’s solid dose facility in Fontaine, France, has been approved for supply of manufactured products to the Japan’s pharmaceuticals market following a recent inspection by the PMDA, the Japanese drug agency. more

Technology